Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
05:06

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise

Published on: July 14, 2023

2.5K

Caterina Palleria1, Christian Leporini1, Francesca Maida1

  • 1Science of Health Department, School of Medicine, University "Magna Graecia" of Catanzaro, Italy.

Frontiers in Neuroendocrinology
|August 14, 2016
PubMed

Insights

Type 2 diabetes can impair cognitive function. Research explores how antidiabetic drugs, beyond glucose control, may offer neuroprotective benefits for the brain.

Area of Science:

  • Endocrinology
  • Neuroscience
  • Metabolic Disorders

Background:

  • Type 2 diabetes mellitus is a complex metabolic disease associated with significant organ damage.
  • Cognitive impairment is a well-documented complication of both type 1 and type 2 diabetes.
  • Current management focuses on blood glucose control, which is insufficient for preventing cognitive decline.

Purpose of the Study:

  • To investigate the potential neuroprotective effects of antidiabetic drugs on the brain.
  • To explore mechanisms beyond glucose-lowering, such as GLP-1, BDNF, and ghrelin pathways.
  • To identify novel therapeutic strategies for diabetic cognitive impairment.

Main Methods:

  • Review of existing literature on antidiabetic drugs and their effects on the brain.
  • Examination of preclinical studies demonstrating the efficacy of certain antidiabetic agents.
  • Analysis of ongoing clinical trials for GLP-1 agonists in neurodegenerative diseases.

Main Results:

  • Antidiabetic drugs may exert beneficial effects on the brain independent of their glycemic control.
  • Mechanisms like GLP-1 agonism show promise, with ongoing research in Parkinson's and Alzheimer's disease.
  • Preclinical data suggest efficacy for other antidiabetic classes in neuroprotection.

Conclusions:

  • Antidiabetic drugs represent a potential therapeutic avenue for mitigating cognitive impairment in diabetes.
  • Further research into the neurobiological effects of these drugs is warranted.
  • Developing new intervention strategies is crucial for addressing this significant comorbidity.
Keywords:
GLP-1GliptinsMetforminNeuroprotectionSulfonylureasThiazolidinediones

More Related Videos

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid06:21

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

2.2K
Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

7.0K

Related Concept Videos

Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
110
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
328
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Drug Therapy01:28

Drug Therapy

The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
331
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
738
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.2K